Panasonic Holdings Corporation
Panasonic Holdings Corporation (PCRFF) Stock Competitors & Peer Comparison
See (PCRFF) competitors and their performances in Stock Market.
Peer Comparison Table: Consumer Electronics Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PCRFF | $9.85 | +0.56% | 23B | 9.29 | $1.06 | +3.30% |
| SSNLF | $40.60 | +0.00% | 265.3B | 8.44 | $4.81 | +2.54% |
| XIACY | $34.55 | -0.52% | 181.2B | 53.11 | $0.65 | N/A |
| XIACF | $6.90 | -1.29% | 179.5B | 53.23 | $0.13 | N/A |
| SNEJF | $25.03 | -2.22% | 150.8B | 19.55 | $1.28 | +0.56% |
| PCRFY | $9.36 | -1.27% | 21.8B | 6.59 | $1.42 | N/A |
| KYOCF | $11.95 | +0.00% | 16.8B | 99.58 | $0.12 | +2.84% |
| KYOCY | $11.36 | +2.16% | 16.1B | 95.00 | $0.12 | +0.55% |
| TCLHF | $1.50 | +35.14% | 3.8B | 16.67 | $0.09 | +3.68% |
| SHCAF | $5.00 | +0.00% | 3.2B | 13.16 | $0.38 | N/A |
Stock Comparison
PCRFF vs SSNLF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, SSNLF has a market cap of 265.3B. Regarding current trading prices, PCRFF is priced at $9.85, while SSNLF trades at $40.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas SSNLF's P/E ratio is 8.44. In terms of profitability, PCRFF's ROE is +0.08%, compared to SSNLF's ROE of +0.09%. Regarding short-term risk, PCRFF is more volatile compared to SSNLF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check SSNLF's competition here
PCRFF vs XIACY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, XIACY has a market cap of 181.2B. Regarding current trading prices, PCRFF is priced at $9.85, while XIACY trades at $34.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas XIACY's P/E ratio is 53.11. In terms of profitability, PCRFF's ROE is +0.08%, compared to XIACY's ROE of +0.16%. Regarding short-term risk, PCRFF is more volatile compared to XIACY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check XIACY's competition here
PCRFF vs XIACF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, XIACF has a market cap of 179.5B. Regarding current trading prices, PCRFF is priced at $9.85, while XIACF trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas XIACF's P/E ratio is 53.23. In terms of profitability, PCRFF's ROE is +0.08%, compared to XIACF's ROE of +0.08%. Regarding short-term risk, PCRFF is less volatile compared to XIACF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check XIACF's competition here
PCRFF vs SNEJF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, SNEJF has a market cap of 150.8B. Regarding current trading prices, PCRFF is priced at $9.85, while SNEJF trades at $25.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas SNEJF's P/E ratio is 19.55. In terms of profitability, PCRFF's ROE is +0.08%, compared to SNEJF's ROE of +0.14%. Regarding short-term risk, PCRFF is more volatile compared to SNEJF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check SNEJF's competition here
PCRFF vs PCRFY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, PCRFY has a market cap of 21.8B. Regarding current trading prices, PCRFF is priced at $9.85, while PCRFY trades at $9.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas PCRFY's P/E ratio is 6.59. In terms of profitability, PCRFF's ROE is +0.08%, compared to PCRFY's ROE of +0.05%. Regarding short-term risk, PCRFF is more volatile compared to PCRFY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check PCRFY's competition here
PCRFF vs KYOCF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, KYOCF has a market cap of 16.8B. Regarding current trading prices, PCRFF is priced at $9.85, while KYOCF trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas KYOCF's P/E ratio is 99.58. In terms of profitability, PCRFF's ROE is +0.08%, compared to KYOCF's ROE of +0.01%. Regarding short-term risk, PCRFF is more volatile compared to KYOCF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check KYOCF's competition here
PCRFF vs KYOCY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, KYOCY has a market cap of 16.1B. Regarding current trading prices, PCRFF is priced at $9.85, while KYOCY trades at $11.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas KYOCY's P/E ratio is 95.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to KYOCY's ROE of +0.01%. Regarding short-term risk, PCRFF is more volatile compared to KYOCY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check KYOCY's competition here
PCRFF vs TCLHF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, TCLHF has a market cap of 3.8B. Regarding current trading prices, PCRFF is priced at $9.85, while TCLHF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas TCLHF's P/E ratio is 16.67. In terms of profitability, PCRFF's ROE is +0.08%, compared to TCLHF's ROE of +0.05%. Regarding short-term risk, PCRFF is more volatile compared to TCLHF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check TCLHF's competition here
PCRFF vs SHCAF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, SHCAF has a market cap of 3.2B. Regarding current trading prices, PCRFF is priced at $9.85, while SHCAF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas SHCAF's P/E ratio is 13.16. In terms of profitability, PCRFF's ROE is +0.08%, compared to SHCAF's ROE of +0.24%. Regarding short-term risk, PCRFF is more volatile compared to SHCAF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check SHCAF's competition here
PCRFF vs SHCAY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, SHCAY has a market cap of 3B. Regarding current trading prices, PCRFF is priced at $9.85, while SHCAY trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas SHCAY's P/E ratio is 12.89. In terms of profitability, PCRFF's ROE is +0.08%, compared to SHCAY's ROE of +0.24%. Regarding short-term risk, PCRFF is more volatile compared to SHCAY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check SHCAY's competition here
PCRFF vs CSIOF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, CSIOF has a market cap of 1.9B. Regarding current trading prices, PCRFF is priced at $9.85, while CSIOF trades at $8.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas CSIOF's P/E ratio is 46.44. In terms of profitability, PCRFF's ROE is +0.08%, compared to CSIOF's ROE of +0.04%. Regarding short-term risk, PCRFF is less volatile compared to CSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check CSIOF's competition here
PCRFF vs CSIOY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, CSIOY has a market cap of 1.8B. Regarding current trading prices, PCRFF is priced at $9.85, while CSIOY trades at $80.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas CSIOY's P/E ratio is 33.76. In terms of profitability, PCRFF's ROE is +0.08%, compared to CSIOY's ROE of +0.04%. Regarding short-term risk, PCRFF is more volatile compared to CSIOY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check CSIOY's competition here
PCRFF vs JVCZY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, JVCZY has a market cap of 1.7B. Regarding current trading prices, PCRFF is priced at $9.85, while JVCZY trades at $46.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas JVCZY's P/E ratio is 15.70. In terms of profitability, PCRFF's ROE is +0.08%, compared to JVCZY's ROE of +0.16%. Regarding short-term risk, PCRFF is less volatile compared to JVCZY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check JVCZY's competition here
PCRFF vs AITUY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, AITUY has a market cap of 1.5B. Regarding current trading prices, PCRFF is priced at $9.85, while AITUY trades at $11.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas AITUY's P/E ratio is 24.71. In terms of profitability, PCRFF's ROE is +0.08%, compared to AITUY's ROE of +0.07%. Regarding short-term risk, PCRFF is more volatile compared to AITUY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check AITUY's competition here
PCRFF vs SWDHY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, SWDHY has a market cap of 1.2B. Regarding current trading prices, PCRFF is priced at $9.85, while SWDHY trades at $13.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas SWDHY's P/E ratio is 13.52. In terms of profitability, PCRFF's ROE is +0.08%, compared to SWDHY's ROE of +0.07%. Regarding short-term risk, PCRFF is more volatile compared to SWDHY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check SWDHY's competition here
PCRFF vs SNCPF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, SNCPF has a market cap of 957.5M. Regarding current trading prices, PCRFF is priced at $9.85, while SNCPF trades at $43.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas SNCPF's P/E ratio is 7.98. In terms of profitability, PCRFF's ROE is +0.08%, compared to SNCPF's ROE of +0.42%. Regarding short-term risk, PCRFF is more volatile compared to SNCPF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check SNCPF's competition here
PCRFF vs SWDHF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, SWDHF has a market cap of 849.8M. Regarding current trading prices, PCRFF is priced at $9.85, while SWDHF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas SWDHF's P/E ratio is 15.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to SWDHF's ROE of +0.06%. Regarding short-term risk, PCRFF is less volatile compared to SWDHF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check SWDHF's competition here
PCRFF vs BGOUF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, BGOUF has a market cap of 313.3M. Regarding current trading prices, PCRFF is priced at $9.85, while BGOUF trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas BGOUF's P/E ratio is -72.33. In terms of profitability, PCRFF's ROE is +0.08%, compared to BGOUF's ROE of -0.03%. Regarding short-term risk, PCRFF is more volatile compared to BGOUF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check BGOUF's competition here
PCRFF vs ADPXY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, ADPXY has a market cap of 117.9M. Regarding current trading prices, PCRFF is priced at $9.85, while ADPXY trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas ADPXY's P/E ratio is -18.83. In terms of profitability, PCRFF's ROE is +0.08%, compared to ADPXY's ROE of +1.75%. Regarding short-term risk, PCRFF is more volatile compared to ADPXY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check ADPXY's competition here
PCRFF vs VTEPF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, VTEPF has a market cap of 92.2M. Regarding current trading prices, PCRFF is priced at $9.85, while VTEPF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas VTEPF's P/E ratio is -0.43. In terms of profitability, PCRFF's ROE is +0.08%, compared to VTEPF's ROE of -0.29%. Regarding short-term risk, PCRFF is more volatile compared to VTEPF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check VTEPF's competition here
PCRFF vs CHWTF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, CHWTF has a market cap of 58.2M. Regarding current trading prices, PCRFF is priced at $9.85, while CHWTF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas CHWTF's P/E ratio is -1.80. In terms of profitability, PCRFF's ROE is +0.08%, compared to CHWTF's ROE of -0.13%. Regarding short-term risk, PCRFF is more volatile compared to CHWTF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check CHWTF's competition here
PCRFF vs DBOXF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, DBOXF has a market cap of 48.2M. Regarding current trading prices, PCRFF is priced at $9.85, while DBOXF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas DBOXF's P/E ratio is 21.68. In terms of profitability, PCRFF's ROE is +0.08%, compared to DBOXF's ROE of +0.27%. Regarding short-term risk, PCRFF is more volatile compared to DBOXF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check DBOXF's competition here
PCRFF vs HAPBF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, HAPBF has a market cap of 14.4M. Regarding current trading prices, PCRFF is priced at $9.85, while HAPBF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas HAPBF's P/E ratio is -3.42. In terms of profitability, PCRFF's ROE is +0.08%, compared to HAPBF's ROE of +2.02%. Regarding short-term risk, PCRFF is more volatile compared to HAPBF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check HAPBF's competition here
PCRFF vs HLOC Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, HLOC has a market cap of 13.9M. Regarding current trading prices, PCRFF is priced at $9.85, while HLOC trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas HLOC's P/E ratio is -16.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to HLOC's ROE of +0.50%. Regarding short-term risk, PCRFF is more volatile compared to HLOC. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check HLOC's competition here
PCRFF vs AMOSF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, AMOSF has a market cap of 47.5K. Regarding current trading prices, PCRFF is priced at $9.85, while AMOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas AMOSF's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.08%, compared to AMOSF's ROE of -8.40%. Regarding short-term risk, PCRFF is more volatile compared to AMOSF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check AMOSF's competition here
PCRFF vs NUHRF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, NUHRF has a market cap of 27.1K. Regarding current trading prices, PCRFF is priced at $9.85, while NUHRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas NUHRF's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to NUHRF's ROE of -3.48%. Regarding short-term risk, PCRFF is less volatile compared to NUHRF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check NUHRF's competition here
PCRFF vs GAXY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, GAXY has a market cap of 23.3K. Regarding current trading prices, PCRFF is priced at $9.85, while GAXY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas GAXY's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to GAXY's ROE of +4.24%. Regarding short-term risk, PCRFF is more volatile compared to GAXY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check GAXY's competition here
PCRFF vs COLCF Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, COLCF has a market cap of 8.3K. Regarding current trading prices, PCRFF is priced at $9.85, while COLCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas COLCF's P/E ratio is -0.04. In terms of profitability, PCRFF's ROE is +0.08%, compared to COLCF's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to COLCF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check COLCF's competition here
PCRFF vs ANDR Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, ANDR has a market cap of 6.8K. Regarding current trading prices, PCRFF is priced at $9.85, while ANDR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas ANDR's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.08%, compared to ANDR's ROE of +0.13%. Regarding short-term risk, PCRFF is more volatile compared to ANDR. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check ANDR's competition here
PCRFF vs BZIC Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, BZIC has a market cap of 6.8K. Regarding current trading prices, PCRFF is priced at $9.85, while BZIC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas BZIC's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.08%, compared to BZIC's ROE of +1.77%. Regarding short-term risk, PCRFF is more volatile compared to BZIC. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check BZIC's competition here
PCRFF vs NGEY Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, NGEY has a market cap of 5.7K. Regarding current trading prices, PCRFF is priced at $9.85, while NGEY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas NGEY's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to NGEY's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to NGEY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check NGEY's competition here
PCRFF vs PUMD Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, PUMD has a market cap of 3.7K. Regarding current trading prices, PCRFF is priced at $9.85, while PUMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas PUMD's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to PUMD's ROE of +0.90%. Regarding short-term risk, PCRFF is more volatile compared to PUMD. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check PUMD's competition here
PCRFF vs CTXV Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, CTXV has a market cap of 2.5K. Regarding current trading prices, PCRFF is priced at $9.85, while CTXV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas CTXV's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to CTXV's ROE of +0.68%. Regarding short-term risk, PCRFF is less volatile compared to CTXV. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check CTXV's competition here
PCRFF vs ZVTK Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, ZVTK has a market cap of 1.4K. Regarding current trading prices, PCRFF is priced at $9.85, while ZVTK trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas ZVTK's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to ZVTK's ROE of +0.00%. Regarding short-term risk, PCRFF is less volatile compared to ZVTK. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check ZVTK's competition here
PCRFF vs GAXYQ Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, GAXYQ has a market cap of 1.2K. Regarding current trading prices, PCRFF is priced at $9.85, while GAXYQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas GAXYQ's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to GAXYQ's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to GAXYQ. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check GAXYQ's competition here
PCRFF vs LTEC Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, LTEC has a market cap of 486. Regarding current trading prices, PCRFF is priced at $9.85, while LTEC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas LTEC's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.08%, compared to LTEC's ROE of -2.97%. Regarding short-term risk, PCRFF is more volatile compared to LTEC. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.Check LTEC's competition here
PCRFF vs CYRD Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, CYRD has a market cap of 343. Regarding current trading prices, PCRFF is priced at $9.85, while CYRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas CYRD's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to CYRD's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to CYRD. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check CYRD's competition here
PCRFF vs NYXO Comparison July 2025
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 23B. In comparison, NYXO has a market cap of 242. Regarding current trading prices, PCRFF is priced at $9.85, while NYXO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 9.29, whereas NYXO's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to NYXO's ROE of +5.00%. Regarding short-term risk, PCRFF is less volatile compared to NYXO. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.Check NYXO's competition here